Use of MG series monoclonal antibodies in the diagnosis and experimental targeting therapy of gastric cancer.

  • 1 March 1991
    • journal article
    • review article
    • Vol. 6  (1) , 56-9
Abstract
In order to facilitate early diagnosis and improve the treatment of gastric cancer, 12 murine hybridoma cell lines capable of producing monoclonal antibodies (mAb) against gastric cancer were established. These monoclonal antibodies were used in histopathological diagnosis, cytological and serological diagnosis, and radioimmunoimaging (RII). Also, immunoconjugates and immunoliposomes were produced by linking these antibodies with various anticancer agents. In vitro and in vivo studies in mice were carried out to investigate the possible uses of these antibodies in experimental targeting therapy of gastric cancer. This paper presents a review of these studies.

This publication has 0 references indexed in Scilit: